Abstract
Type 1 diabetes mellitus (T1DM) is classified as an autoimmune disease which progressively results in the depletion of insulin-secreting β-cells. Consequently, the insulin secretion stops leading to hyperglycemic situations within the body. Under severe conditions, it also causes multi-organ diabetes-associated dysfunctionalities notably hypercoagulability, neuropathy, nephropathy, retinopathy, and sometimes organ failures. The prevalence of this disease has been noticed about 3% that has highlighted the serious concerns for healthcare professionals around the globe. For the treatment of this disease, the cell therapy is considered as an important therapeutic approach for the replacement of damaged β-cells. However, the development of autoantibodies unfortunately reduces their effectiveness with the passage of time and finally with the recurrence of diabetes mellitus. The development of new techniques for extraction and transplantation of islets failed to support this approach due to the issues related to major surgery and lifelong dependence on immunosuppression. For T1DM, such cells are supposed to produce, store, and supply insulin to maintain glucose homeostasis. The urgent need of much-anticipated substitute for insulin-secreting β-cells directed the researchers to focus on stem cells (SCs) to produce insulin-secreting β-cells. For being more specific and targeted therapeutic approaches, SC-based strategies opened up the new horizons to cure T1DM. This cell-based therapy aimed to produce functional insulin-secreting β-cells to cure diabetes on forever basis. The intrinsic regenerative potential along with immunomodulatory abilities of SCs highlights the therapeutic potential of SC-based strategies. In this article, we have comprehensively highlighted the role of SCs to treat diabetes mellitus.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- CPPs:
-
Cell-penetrating peptides
- ESCs:
-
Embryonic stem cells
- HSCs:
-
Hematopoietic stem cells
- HSV:
-
Herpes simplex virus
- iPSCs:
-
Induced pluripotent stem cells
- ISC:
-
Insulin-secreting cells
- MSCs:
-
Mesenchymal stromal cells
- PTDs:
-
Protein transduction domains
- r-ATG:
-
Rabbit anti-thymoglobulin
- SCs:
-
Stem cells
- SCT:
-
Stem cell therapy
- T1DM:
-
Type 1 diabetes mellitus
- TAT:
-
Trans-activator of transcription
- UCB:
-
Umbilical cord blood
- WHO:
-
World Health Organization
References
American Diabetes, A. (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care, 33(Suppl 1), S62–S69. https://doi.org/10.2337/dc10-S062.
Assady, S., Maor, G., Amit, M., Itskovitz-Eldor, J., Skorecki, K. L., & Tzukerman, M. (2001). Insulin production by human embryonic stem cells. Diabetes, 50(8), 1691–1697.
Ball, S. G., & Barber, T. M. (2003). Molecular development of the pancreatic beta cell: Implications for cell replacement therapy. Trends Endocrinol Metab, 14(8), 349–355.
Barcala Tabarrozzi, A. E., Castro, C. N., Dewey, R. A., Sogayar, M. C., Labriola, L., & Perone, M. J. (2013). Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus. Clin Exp Immunol, 171(2), 135–146. https://doi.org/10.1111/cei.12019.
Bianco, P., & Robey, P. G. (2001). Stem cells in tissue engineering. Nature, 414(6859), 118–121.
Bonner-Weir, S., Baxter, L. A., Schuppin, G. T., & Smith, F. E. (1993). A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes, 42(12), 1715–1720.
Buzzetti, R., Cernea, S., Petrone, A., Capizzi, M., Spoletini, M., Zampetti, S.,. .. Pozzilli, P. (2011). C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory study. Diabetes, 60(11), 3067–3072. doi: https://doi.org/10.2337/db10-0560
Cefalu, W. T. (2012). American diabetes association-European association for the study of diabetes position statement: Due diligence was conducted. Diabetes Care, 35(6), 1201–1203. https://doi.org/10.2337/dc12-0564.
Concannon, P., Rich, S. S., & Nepom, G. T. (2009). Genetics of Type 1A diabetes. New England Journal of Medicine, 360(16), 1646–1654. https://doi.org/10.1056/NEJMra0808284.
Couri, C. E. B., & Voltarelli, J. C. (2009). Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials. Diabetology & Metabolic Syndrome, 1(1), 19. https://doi.org/10.1186/1758-5996-1-19.
Czaja, A. J. (2014). Current and prospective pharmacotherapy for autoimmune hepatitis. Expert Opinion on Pharmacotherapy, 15(12), 1715–1736. https://doi.org/10.1517/14656566.2014.931938.
Czaja, A. J. (2016). Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. Gut Liver, 10(2), 177–203. https://doi.org/10.5009/gnl15352.
D’Amour, K. A., Bang, A. G., Eliazer, S., Kelly, O. G., Agulnick, A. D., Smart, N. G.,. .. Baetge, E. E. (2006). Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol, 24(11), 1392–1401. doi: https://doi.org/10.1038/nbt1259
Dominguez-Bendala, J., Klein, D., Ribeiro, M., Ricordi, C., Inverardi, L., Pastori, R., & Edlund, H. (2005). TAT-mediated neurogenin 3 protein transduction stimulates pancreatic endocrine differentiation in vitro. Diabetes, 54(3), 720–726.
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D.,. .. Horwitz, E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315–317. doi: https://doi.org/10.1080/14653240600855905
Dube, S., Errazuriz, I., Cobelli, C., Basu, R., & Basu, A. (2013). Assessment of insulin action on carbohydrate metabolism: Physiological and non-physiological methods. Diabet Med, 30(6), 664–670. https://doi.org/10.1111/dme.12189.
Eaton, R. P., Allen, R. C., Schade, D. S., Erickson, K. M., & Standefer, J. (1980). Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab, 51(3), 520–528. https://doi.org/10.1210/jcem-51-3-520.
Elliott, R. B., Crossley, J. R., Berryman, C. C., & James, A. G. (1981). Partial preservation of pancreatic β-cell function in children with diabetes. The Lancet, 318(8247), 631–632. https://doi.org/10.1016/S0140-6736(81)92761-6.
Fiorina, P., Jurewicz, M., Augello, A., Vergani, A., Dada, S., La Rosa, S.,. .. Abdi, R. (2009). Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol, 183(2), 993–1004. doi: https://doi.org/10.4049/jimmunol.0900803
Fiorina, P., Voltarelli, J., & Zavazava, N. (2011). Immunological applications of stem cells in type 1 diabetes. Endocr Rev, 32(6), 725–754. https://doi.org/10.1210/er.2011-0008.
Fotino, N., Fotino, C., & Pileggi, A. (2015). Re-engineering islet cell transplantation. Pharmacol Res, 98, 76–85. https://doi.org/10.1016/j.phrs.2015.02.010.
Friedenstein, A. J., Piatetzky, S., II, & Petrakova, K. V. (1966). Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol, 16(3), 381–390.
Geoghegan, E., & Byrnes, L. (2008). Mouse induced pluripotent stem cells. International Journal of Developmental Biology, 52(8), 1015–1022.
Gibly, R. F., Graham, J. G., Luo, X., Lowe, W. L., Jr., Hering, B. J., & Shea, L. D. (2011). Advancing islet transplantation: from engraftment to the immune response. Diabetologia, 54(10), 2494–2505. https://doi.org/10.1007/s00125-011-2243-0.
Greenbaum, C., & Atkinson, M. A. (2011). Persistence is the twin sister of excellence: an important lesson for attempts to prevent and reverse type 1 diabetes. Diabetes, 60(3), 693–694. https://doi.org/10.2337/db10-1810.
Gruessner, A. C., & Sutherland, D. E. (2005). Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant, 19(4), 433–455. https://doi.org/10.1111/j.1399-0012.2005.00378.x.
Haidara, M. A., Assiri, A. S., Youssef, M. A., Mahmoud, M. M., Ahmed M.S., E., Al-Hakami, A., & Chandramoorthy, H. C. (2015). Differentiated mesenchymal stem cells ameliorate cardiovascular complications in diabetic rats. Cell and Tissue Research, 359(2), 565–575. doi: https://doi.org/10.1007/s00441-014-2034-2
Halban, P. A. (2004). Cellular sources of new pancreatic beta cells and therapeutic implications for regenerative medicine. Nat Cell Biol, 6(11), 1021–1025. https://doi.org/10.1038/ncb1104-1021.
Haller, M. J., Wasserfall, C. H., McGrail, K. M., Cintron, M., Brusko, T. M., Wingard, J. R.,. .. Schatz, D. A. (2009). Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care, 32(11), 2041–2046. doi: https://doi.org/10.2337/dc09-0967
Harjutsalo, V., Sjoberg, L., & Tuomilehto, J. (2008). Time trends in the incidence of type 1 diabetes in Finnish children: A cohort study. Lancet, 371(9626), 1777–1782. https://doi.org/10.1016/s0140-6736(08)60765-5.
Hoogduijn, M. J., Popp, F., Verbeek, R., Masoodi, M., Nicolaou, A., Baan, C., & Dahlke, M. H. (2010). The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. Int Immunopharmacol, 10(12), 1496–1500. https://doi.org/10.1016/j.intimp.2010.06.019.
Hori, Y., Gu, X., Xie, X., & Kim, S. K. (2005). Differentiation of insulin-producing cells from human neural progenitor cells. PLoS Med, 2(4), e103. https://doi.org/10.1371/journal.pmed.0020103.
Jahansouz, C., Kumer, S. C., Ellenbogen, M., & Brayman, K. L. (2011). Evolution of beta-Cell replacement therapy in diabetes mellitus: Pancreas transplantation. Diabetes Technol Ther, 13(3), 395–418. https://doi.org/10.1089/dia.2010.0133.
Jurewicz, M., Yang, S., Augello, A., Godwin, J. G., Moore, R. F., Azzi, J.,. .. Abdi, R. (2010). Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes. Diabetes, 59(12), 3139–3147. doi: https://doi.org/10.2337/db10-0542
Karnieli, O., Izhar-Prato, Y., Bulvik, S., & Efrat, S. (2007). Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells, 25(11), 2837–2844. https://doi.org/10.1634/stemcells.2007-0164.
Kilk, K., Magzoub, M., Pooga, M., Eriksson, L. E., Langel, U., & Graslund, A. (2001). Cellular internalization of a cargo complex with a novel peptide derived from the third helix of the islet-1 homeodomain. Comparison with the penetrating peptide. Bioconjug Chem, 12(6), 911–916.
Kukko, M., Kimpimaki, T., Korhonen, S., Kupila, A., Simell, S., Veijola, R.,. .. Knip, M. (2005). Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population. J Clin Endocrinol Metab, 90(5), 2712–2717. doi: https://doi.org/10.1210/jc.2004-1371
Li, Y., Zhang, R., Qiao, H., Zhang, H., Wang, Y., Yuan, H.,. .. Pei, X. (2007). Generation of insulin-producing cells from PDX-1 gene-modified human mesenchymal stem cells. J Cell Physiol, 211(1), 36–44. doi: https://doi.org/10.1002/jcp.20897
Liu, X., Wang, Y., Li, Y., & Pei, X. (2013). Research status and prospect of stem cells in the treatment of diabetes mellitus. Science China Life Sciences, 56(4), 306–312. https://doi.org/10.1007/s11427-013-4469-1.
Lumelsky, N., Blondel, O., Laeng, P., Velasco, I., Ravin, R., & McKay, R. (2001). Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science, 292(5520), 1389–1394. https://doi.org/10.1126/science.1058866.
Manns, M. P., & Strassburg, C. P. (2011). Therapeutic strategies for autoimmune hepatitis. Digestive Diseases, 29(4), 411–415.
Martin, G. R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A, 78(12), 7634–7638.
Masoud, M. S., Anwar, S. S., Afzal, M. Z., Mehmood, A., Khan, S. N., & Riazuddin, S. (2012). Pre-conditioned mesenchymal stem cells ameliorate renal ischemic injury in rats by augmented survival and engraftment. Journal of Translational Medicine, 10(1), 243. https://doi.org/10.1186/1479-5876-10-243.
Noguchi, H., & Matsumoto, S. (2006). Protein transduction technology offers a novel therapeutic approach for diabetes. Journal of Hepato-Biliary-Pancreatic Surgery, 13(4), 306–313. https://doi.org/10.1007/s00534-005-1038-4.
Noguchi, H., Kaneto, H., Weir, G. C., & Bonner-Weir, S. (2003). PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells. Diabetes, 52(7), 1732–1737.
Noguchi, H., Bonner-Weir, S., Wei, F. Y., Matsushita, M., & Matsumoto, S. (2005). BETA2/NeuroD protein can be transduced into cells due to an arginine- and lysine-rich sequence. Diabetes, 54(10), 2859–2866.
Oh, S. H., Muzzonigro, T. M., Bae, S. H., LaPlante, J. M., Hatch, H. M., & Petersen, B. E. (2004). Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab Invest, 84(5), 607–617. https://doi.org/10.1038/labinvest.3700074.
Okita, K., Yamakawa, T., Matsumura, Y., Sato, Y., Amano, N., Watanabe, A.,. .. Yamanaka, S. (2013). An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells, 31(3), 458–466. doi: https://doi.org/10.1002/stem.1293
Orban, T., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R.,. .. Skyler, J. S. (2011). Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet, 378(9789), 412–419. doi: https://doi.org/10.1016/s0140-6736(11)60886-6
Ostman, J., Lonnberg, G., Arnqvist, H. J., Blohme, G., Bolinder, J., Ekbom Schnell, A.,. .. Nystrom, L. (2008). Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983–2002. J Intern Med, 263(4), 386–394. doi: https://doi.org/10.1111/j.1365-2796.2007.01896.x
Pozzilli, P. (2012). Type 1 diabetes mellitus in 2011: Heterogeneity of T1DM raises questions for therapy. Nat Rev. Endocrinol, 8(2), 78–80.
Prokhorova, T. A., Harkness, L. M., Frandsen, U., Ditzel, N., Schroder, H. D., Burns, J. S., & Kassem, M. (2009). Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel. Stem Cells Dev, 18(1), 47–54. https://doi.org/10.1089/scd.2007.0266.
Rackham, C. L., Chagastelles, P. C., Nardi, N. B., Hauge-Evans, A. C., Jones, P. M., & King, A. J. (2011). Co-transplantation of mesenchymal stem cells maintains islet organisation and morphology in mice. Diabetologia, 54(5), 1127–1135. https://doi.org/10.1007/s00125-011-2053-4.
Rahier, J., Goebbels, R. M., & Henquin, J. C. (1983). Cellular composition of the human diabetic pancreas. Diabetologia, 24(5), 366–371.
Ramirez-Dominguez, M. (2016). Historical background of pancreatic islet isolation. Adv Exp Med Biol, 938, 1–9. https://doi.org/10.1007/978-3-319-39824-2_1.
Ramiya, V. K., Maraist, M., Arfors, K. E., Schatz, D. A., Peck, A. B., & Cornelius, J. G. (2000). Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med, 6(3), 278–282. https://doi.org/10.1038/73128.
Ricordi, C., Lacy, P. E., & Scharp, D. W. (1989). Automated islet isolation from human pancreas. Diabetes, 38(Suppl 1), 140–142.
Ryan, E. A., Paty, B. W., Senior, P. A., Bigam, D., Alfadhli, E., Kneteman, N. M.,. .. Shapiro, A. M. (2005). Five-year follow-up after clinical islet transplantation. Diabetes, 54(7), 2060–2069.
Santana, A., Ensenat-Waser, R., Arribas, M. I., Reig, J. A., & Roche, E. (2006). Insulin-producing cells derived from stem cells: recent progress and future directions. J Cell Mol Med, 10(4), 866–883.
Schloot, N. C., Meierhoff, G., Lengyel, C., Vandorfi, G., Takacs, J., Panczel, P.,. .. Jermendy, G. (2007). Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials. Diabetes Metab Res Rev., 23(4), 276–285. doi: https://doi.org/10.1002/dmrr.707
Seaberg, R. M., Smukler, S. R., Kieffer, T. J., Enikolopov, G., Asghar, Z., Wheeler, M. B.,. .. van der Kooy, D. (2004). Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol, 22(9), 1115–1124. doi: https://doi.org/10.1038/nbt1004
Segev, H., Fishman, B., Ziskind, A., Shulman, M., & Itskovitz-Eldor, J. (2004). Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells, 22(3), 265–274. https://doi.org/10.1634/stemcells.22-3-265.
Shih, C. C., Forman, S. J., Chu, P., & Slovak, M. (2007). Human embryonic stem cells are prone to generate primitive, undifferentiated tumors in engrafted human fetal tissues in severe combined immunodeficient mice. Stem Cells Dev, 16(6), 893–902. https://doi.org/10.1089/scd.2007.0070.
Soria, B., Roche, E., Berna, G., Leon-Quinto, T., Reig, J. A., & Martin, F. (2000). Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes, 49(2), 157–162.
Sprent, J., & Kishimoto, H. (2001). The thymus and central tolerance. Philos Trans R Soc Lond B Biol Sci, 356(1409), 609–616. https://doi.org/10.1098/rstb.2001.0846.
Staeva, T. P., Chatenoud, L., Insel, R., & Atkinson, M. A. (2013). Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials. Diabetes, 62(1), 9–17. https://doi.org/10.2337/db12-0562.
Starzl, T. E. (2001). The “privileged” liver and hepatic tolerogenicity. Liver Transplantation, 7(10), 918–920. https://doi.org/10.1053/jlts.2001.0070918.
Stefan, Y., Orci, L., Malaisse-Lagae, F., Perrelet, A., Patel, Y., & Unger, R. H. (1982). Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes, 31(8 Pt 1), 694–700.
Sun, Y., Chen, L., Hou, X. G., Hou, W. K., Dong, J. J., Sun, L.,. .. Wang, K. X. (2007). Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chinese Medical Journal (Engl), 120(9), 771–776.
Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663–676. https://doi.org/10.1016/j.cell.2006.07.024.
Tariq, M., Masoud, M. S., Mehmood, A., Khan, S. N., & Riazuddin, S. (2013). Stromal cell derived factor-1alpha protects stem cell derived insulin-producing cells from glucotoxicity under high glucose conditions in-vitro and ameliorates drug induced diabetes in rats. Journal of Translational Medicine, 11(1), 115. https://doi.org/10.1186/1479-5876-11-115.
Thakkar, U. G., Trivedi, H. L., Vanikar, A. V., & Dave, S. D. (2015). Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus. Cytotherapy, 17(7), 940–947. https://doi.org/10.1016/j.jcyt.2015.03.608.
Trivedi, H. L., & Vanikar, A. V. (2013). Mesenchymal stem cells and solid organ transplantation. CellR4, 1(2), 123–136.
Trivedi, H. L., Vanikar, A. V., Thakker, U., Firoze, A., Dave, S. D., Patel, C. N.,. .. Shankar, V. (2008). Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin. Transplantation Proceedings, 40(4), 1135–1139. doi: https://doi.org/10.1016/j.transproceed.2008.03.113
Urban, V. S., Kiss, J., Kovacs, J., Gocza, E., Vas, V., Monostori, E., & Uher, F. (2008). Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells, 26(1), 244–253. https://doi.org/10.1634/stemcells.2007-0267.
Vanikar, A. V., Dave, S. D., Thakkar, U. G., & Trivedi, H. L. (2010). Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: A novel therapy for insulin-dependent diabetes mellitus. Stem Cells International. https://doi.org/10.4061/2010/582382.
Vanikar, A. V., Trivedi, H. L., & Thakkar, U. G. (2016). Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus. Cytotherapy, 18(9), 1077–1086. https://doi.org/10.1016/j.jcyt.2016.06.006.
Voltarelli, J. C., Couri, C. E., Stracieri, A. B., Oliveira, M. C., Moraes, D. A., Pieroni, F.,. .. Burt, R. K. (2007). Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA, 297(14), 1568–1576. doi: https://doi.org/10.1001/jama.297.14.1568
Voltarelli, J. C., Couri, C. E., Stracieri, A. B., Oliveira, M. C., Moraes, D. A., Pieroni, F.,. .. Burt, R. K. (2008). Autologous hematopoietic stem cell transplantation for type 1 diabetes. Annals of the New York Academy of Sciences, 1,150, 220–229. doi: https://doi.org/10.1196/annals.1447.048
Walter, M., Philotheou, A., Bonnici, F., Ziegler, A. G., & Jimenez, R. (2009). No effect of the altered peptide ligand NBI-6024 on beta-cell residual function and insulin needs in new-onset type 1 diabetes. Diabetes Care, 32(11), 2036–2040. https://doi.org/10.2337/dc09-0449.
Wang, R. N., Kloppel, G., & Bouwens, L. (1995). Duct- to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rats. Diabetologia, 38(12), 1405–1411.
Werbowetski-Ogilvie, T. E., Bosse, M., Stewart, M., Schnerch, A., Ramos-Mejia, V., Rouleau, A.,. .. Bhatia, M. (2009). Characterization of human embryonic stem cells with features of neoplastic progression. Nature Biotechnology, 27(1), 91–97. doi: https://doi.org/10.1038/nbt.1516
Wherrett, D. K., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R.,. .. Skyler, J. S. (2011). Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial. Lancet, 378(9788), 319–327. doi: https://doi.org/10.1016/s0140-6736(11)60895-7
Xu, X., D’Hoker, J., Stange, G., Bonne, S., De Leu, N., Xiao, X.,. .. Heimberg, H. (2008). Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell, 132(2), 197–207. doi: https://doi.org/10.1016/j.cell.2007.12.015
Yeung, W. C., Rawlinson, W. D., & Craig, M. E. (2011). Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ, 342, d35. https://doi.org/10.1136/bmj.d35.
Yoon, J. W., & Jun, H. S. (2005). Autoimmune destruction of pancreatic beta cells. American Journal of Therapeutics, 12(6), 580–591.
Zimmet, P., Alberti, K. G., & Shaw, J. (2001). Global and societal implications of the diabetes epidemic. Nature, 414(6865), 782–787. https://doi.org/10.1038/414782a.
Conflict of Interest
Nothing to declare.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this paper
Cite this paper
Farooq, T., Rehman, K., Hameed, A., Akash, M.S.H. (2018). Stem Cell Therapy and Type 1 Diabetes Mellitus: Treatment Strategies and Future Perspectives. In: Pham, P. (eds) Tissue Engineering and Regenerative Medicine. Advances in Experimental Medicine and Biology(), vol 1084. Springer, Cham. https://doi.org/10.1007/5584_2018_195
Download citation
DOI: https://doi.org/10.1007/5584_2018_195
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-19856-5
Online ISBN: 978-3-030-19857-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)